TAM
AXDX

Telluride Asset Management’s Accelerate Diagnostics AXDX Stock Holding History

Telluride Asset Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,034
Closed -$126K – 244
2013
Q4 		$126K Buy
+1,034
New +$138K 0.15% 163

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
WIC
Wood Investment Counsel Denver, Colorado $669M AUM 20.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telluride Asset Management's AXDX Position: Q1 2014 in Review

Telluride Asset Management sold out of Accelerate Diagnostics (AXDX) in Q1 2014, closing a stake of 1,034 shares — an estimated $126K sold.

Telluride Asset Management first reported a position in AXDX in Q4 2013 and held it in 1 quarter. The position peaked at $126K in Q4 2013. 56 funds tracked by Wall St. Rank hold AXDX as of Q1 2014.

  • Telluride Asset Management reported no remaining Accelerate Diagnostics position as of Q1 2014 after selling out during the quarter.
  • Telluride Asset Management sold 1,034 Accelerate Diagnostics shares in Q1 2014, an estimated $126K.
  • Telluride Asset Management first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 1 quarter.
  • Telluride Asset Management's Accelerate Diagnostics position peaked at $126K in Q4 2013.
  • 56 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2014.

Based on Telluride Asset Management's 13F filing for Q1 2014, filed 14 May 2014.